MHRA (UK)
OTHER
MHRA Safety Roundup: September 2026
Published: 9/29/2026Detected: 9/29/2026
Summary preview
Provides a curated safety update for medicines and medical device users, highlighting the latest safety advice issued by the MHRA.
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountsafety
labeling
clinical
manufacturing
quality
#MHRA
#safety advice
#pharmacovigilance
#post-market surveillance
#risk minimisation
Official Source Document Source Verified
Access the original document directly from MHRA.
More from MHRA (UK)
- Class 4 Medicines Defect Notification: Neuraxpharm UK Limited, Levetiracetam Neuraxpharm granules for oral solution in sachet, EL(26)A/4010/1/2026
- Field Safety Notices: 21 to 25 September 20269/29/2026
- Class 4 Medicines Defect Notification: B. Braun Melsungen AG, Meropenem 1000 mg powder and solvent for solution for infusion, EL(26)A/399/23/2026
- Field Safety Notices: 14 to 18 September 20269/23/2026
- Radiofrequency (RF) Safety Considerations for Wireless Cardiotocography (CTG) Monitoring Systems (DSI/2026/012)9/17/2026